Single-Arm Phase II Survival Trial Design

Single-Arm Phase II Survival Trial Design
English | 2022 | ISBN: 0367653451 | 274 Pages | PDF (True) | 3.35 MB
Single-Arm Phase II Survival Trial Design provides a comprehensive summary to the most commonly- used methods for single-arm phase II trial design with time-to-event endpoints. Single-arm phase II trials are a key component for successfully developing advanced cancer drugs and treatments, particular for target therapy and immunotherapy in which time-to-event endpoints are often the primary endpoints. Most test statistics for single-arm phase II trial design with time-to-event endpoints are not available in commercial software.